As a parent of a child with food allergies, I am always seeking out the latest news and research in an effort to improve my son’s overall health and quality of life. For this reason, I attended Europe’s leading conference on food allergies: the Food Allergy and Anaphylaxis Meeting (FAAM) in Dublin, hosted by the European Academy of Allergy and Clinical Immunology (EAACI). With about 600 participants from roughly 50 countries, the multidisciplinary seminars at FAAM 2014 covered various topics related to managing food allergies, as well as prevention and finding a cure.
EAACI represents doctors, researchers and other medical professionals. It has over 7,800 individual members and also works with National Societies and patient organizations, such as the aha! Swiss Allergy Center in Bern. Most recently, I wrote about EAACI’s efforts to raise awareness of food allergies via a written declaration on allergic disease presented before the European Parliament.
FAAM 2014: A Few Highlights
The FAAM 2014 seminars spanned over three days, and nearly 200 abstracts were presented as part of the conference. In the coming weeks and months, you’ll notice that these seminars will be informing many of my future blog posts, as well as the management of our son’s allergies (e.g., requesting a consultation with a nutritionist). In the meantime, I just wanted to share a few of the key findings presented at the conference that I found especially interesting.
- Mr. Jerry Buttimer TD (Ireland), a member of the Irish Parliament, said that if President Barack Obama can sign into law a bill encouraging schools in the United States to have access to epinephrine (a.k.a. adrenaline) auto-injectors, then surely a similar law could be passed across Europe. Mr. Buttimer was referring to the School Access to Emergency Epinephrine Act (H.R. 2094), which enables states to pass legislation requiring schools to carry “stock” epinephrine auto-injectors for emergency use.
- Dr. Audrey Dunn Galvin (Ireland), a registered physiologist and lecturer at the University College Cork, presented her research on the socioeconomic cost of food allergies. She discussed the high levels of stress and anxiety that parents can experience due to the constant monitoring of their child’s food allergies. In particular, she discussed how parents must balance the need to protect their child’s environment, while ensuring their positive development. In addition, she mentioned several recent studies socioeconomic costs, including a study of adults with food allergies in Sweden.
Oral Food Challenges
- Dr. Carina Venter (United Kingdom) talked about food challenges as the best way to identify a true food allergy, and questioned the reliability of self-reported data to determine the prevalence of food allergies. Overall, she stressed the need for more and better data on food allergy prevalence, particularly to evaluate changes over time. As part of her presentation, Dr. Venter discussed her research on trends in the prevalence of peanut allergies in the UK.
- Dr. Galvin’s research on the socioeconomic impact of food allergies found that routine oral food challenges help to improve health-related quality of life for families living with food allergies. From our own experience, I certainly find this to be true, as food challenges have either allowed us to introduce new foods into our son’s diet or have provided us with greater knowledge and awareness of his allergies, even though he didn’t “pass” the test.
- Dr. Margitta Worm (Germany) discussed her research examining an anaphylaxis registry for German-speaking countries, including Switzerland. Her study found that adrenaline was rarely used. More specifically, for the emergency treatment of anaphylaxis among 197 children and adolescents between 2006 and 2009, adrenaline was used in only 22 percent of the registered cases.
- Dr. Kirsten Beyer (Germany) described oral immunotherapy (OIT) as a promising treatment for allergies, but highlighted that it is not yet ready for clinical practice. She said that many different protocols exist for OIT, which makes it difficult to compare results and assess its effectiveness. Generally, researchers agree on three primary phases for this treatment: 1) a starting dose, 2) dose escalation and 3) a maintenance dose. During her presentation, she cited a recent study on the side effects of OIT for peanut allergy.
You can also review the tweets from other FAAM 2014 participants by searching for the event hashtag via Twitter: #FAAM2014.
EAACI Food Allergy and Anaphylaxis Guidelines
Throughout FAAM 2014, presenters referred to the EAACI Food Allergy and Anaphylaxis Guidelines, which were published earlier this year. The purpose of these guidelines is to translate knowledge of food allergies into clinical practice, and in particular, for such areas as diagnosis and management, prevention, quality of life and anaphylaxis. EAACI included a hard copy of these guidelines as part of the printed materials I received during the conference, and I will be sharing what I learn as I review them. While the full document is only available for EAACI members to download, sections of the guidelines are also via the EAACI website.
I will continue to provides updates on the research presented at FAAM 2014, and next week, I also plan on sharing a recipe from our excursion to Northern Ireland. Bon week-end, everyone! Thanks for your continued support.